Biden’s New HIV/AIDS Strategy Calls Racism a Roadblock to Victory
Strategy outlines the direction of the White House's policies, research, programs, and planning for the next three years
Many Hospitals Lack All-Trans Retinoic Acid for Treating Leukemia
Only 14 percent of hospitals that referred patients with acute promyelocytic leukemia had ATRA readily available
Most Immunosuppressive Meds Not Tied to Worse COVID-19 Outcomes
Except for rituximab, no increased risk seen for in-hospital death or mechanical ventilation for those on long-term immunosuppressive therapy
Concurrent Zoster, Flu Vaccines Tied to Lower Subsequent Flu Vaccine Uptake
Patients may misattribute adverse effects commonly caused by the zoster vaccine to the influenza vaccine
First U.S. Omicron Case Reported in California
Patient was a traveler, apparently from the San Francisco area, who returned from South Africa on Nov. 22
First Overdose Prevention Centers in the Nation Open in NYC
Cities and states nationwide have pushed for overdose prevention sites in recent years
Giving Nivolumab/Ipilimumab First Ups Overall Survival in Melanoma
Two-year overall survival 72 percent for those starting with N/I, 52 percent for those starting with dabrafenib/trametinib
Colchicine No Benefit Over Supportive Care for COVID-19
No significant reduction reported in mortality, ventilatory support, ICU admission, length of stay, serious adverse events; increase seen in adverse events, diarrhea
AAV Gene Transfer Feasible for the Treatment of Hemophilia A
In a phase 1-2 trial, 16 of 18 men had sustained expression of factor VIII after gene transfer with adeno-associated viral vector (SPK-8011)
ATS: Consider FEɴᴏ Test for Optimizing Asthma Treatment
The use of FENO testing in addition to usual care is suggested for patients with asthma in whom treatment is being considered